Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2017-11-20
ASNSArsanis, Inc.Embl Technology Fund II Gmbh & Co. Kg10%P - Purchase$10.00+20,000370,454+6%+$200,000
D
2017-11-20
ASNSArsanis, Inc.Neomed Innovation V L.P.10%P - Purchase$10.00+300,000867,639+53%+$3,000,000
D
2017-11-20
ASNSArsanis, Inc.Nessi ClaudioDirP - Purchase$10.00+300,000867,639+53%+$3,000,000
D
2017-11-20
ASNSArsanis, Inc.Svlsf V, LLC10%P - Purchase$10.00+500,0001,868,961+37%+$5,000,000
D
2017-11-20
ASNSArsanis, Inc.McGuire TerranceDir, 10%P - Purchase$10.00+500,0001,821,460+38%+$5,000,000
D
2017-11-20
ASNSArsanis, Inc.Gerngross Tillman U.DirP - Purchase$10.00+200,000392,821+104%+$2,000,000
D
2017-11-20
ASNSArsanis, Inc.Gordon Carl LDir, 10%P - Purchase$10.00+500,0001,868,966+37%+$5,000,000
D
2017-11-20
ASNSArsanis, Inc.Polaris Venture Management Co. V, L.L.C.10%P - Purchase$10.00+500,0001,821,460+38%+$5,000,000
D
2017-11-20
ASNSArsanis, Inc.Ross Michael JayDir, 10%P - Purchase$10.00+500,0001,868,961+37%+$5,000,000
D
2017-11-16
ONCESpark Therapeutics, Inc.Webster Stephen WCFOS - Sale+OE$70.14-10,0002,500-80%-$701,400
2017-11-15
SGENSeattle Genetics Inc /waLippman Marc EDirS - Sale$58.07-3,000132,050-2%-$174,224
DM
2017-11-15
SGENSeattle Genetics Inc /waDobmeier EricCOOS - Sale+OE$58.25-35,000117,424-23%-$2,038,724
D
2017-11-17
ATRAAtara Biotherapeutics, Inc.Soffer GadEVP, Chief Strategy OfficerS - Sale+OE$15.00-7,000256,236-3%-$105,000
D
2017-11-15
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale+OE$13.36-1,604362,5300%-$21,429
D
2017-11-16
ATRAAtara Biotherapeutics, Inc.Clark Mitchall G.EVP, Chief R, QA OfficerS - Sale+OE$14.20-3,290163,052-2%-$46,718
D
2017-11-16
ATRAAtara Biotherapeutics, Inc.Gallagher Carol GiltnerDirS - Sale+OE$14.20-1,184109,738-1%-$16,813
D
2017-11-16
BOLDAudentes Therapeutics, Inc.Newman MarySVP, Regulatory AffairsS - Sale+OE$26.84-10,0000-100%-$268,375
D
2017-11-15
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$73.05-9,90013,157-43%-$723,191
2017-11-15
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$25.30-5,00087,283-5%-$126,500
A
2017-11-09
ADMAAdma Biologics, Inc.Biotest AGDir, 10%P - Purchase$2.15+5,813,95418,700,694+45%+$12,500,001
2017-11-16
CRISCuris IncRubin MarcDirP - Purchase$0.98+25,00051,596+94%+$24,500
2017-11-15
CDTXCidara Therapeutics, Inc.Biotech Target N V10%P - Purchase$7.57+60,0002,295,272+3%+$453,966
D
2017-11-13
NSTGNanostring Technologies IncGhesquiere David W.SVP, Corporate, Business DevS - Sale+OE$8.14-68916,638-4%-$5,608
2017-11-13
BCRXBiocryst Pharmaceuticals IncSheridan William PSVP - CMOS - Sale$4.72-64,31023,855-73%-$303,543
D
2017-11-13
GILDGilead Sciences IncMilligan John FPres, CEOS - Sale+OE$72.88-220,0001,165,924-16%-$16,034,678
2017-11-15
CRISCuris IncFattaey Ali Ph.D.Pres, CEOP - Purchase$1.06+50,000115,890+76%+$53,000
M
2017-11-13
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$13.47-4,4001,157,5450%-$59,268
D
2017-11-10
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$58.00-18,832687,146-3%-$1,092,193
2017-11-13
AMGNAmgen IncHarper Sean EEVP, Research, DevelopmentS - Sale$171.58-1,52557,631-3%-$261,660
2017-11-14
PRTOProteon Therapeutics IncEldridge, George ArthurSVP, CFO, Treasr, Asst SecyP - Purchase$1.69+29514,295+2%+$499
D
2017-11-10
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$149.58-9,90027,305-27%-$1,480,865
2017-11-10
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale$13.25-1,852637,1870%-$24,539
2017-11-10
MNTAMomenta Pharmaceuticals IncLeicher BruceSVP, GCS - Sale$13.07-355173,3220%-$4,640
2017-11-10
MNTAMomenta Pharmaceuticals IncKaundinya Ganesh VenkataramanCOO, CSOS - Sale$13.12-392488,0290%-$5,143
2017-11-10
VICLVical IncMerton Robert CDirP - Purchase$1.75+85,70095,451+879%+$149,975
D
2017-11-13
ONCESpark Therapeutics, Inc.Marrazzo Jeffrey DCEOS - Sale+OE$71.54-20,000230,000-8%-$1,430,800
DM
2017-11-09
ONCESpark Therapeutics, Inc.La Barge JosephGCS - Sale+OE$71.44-5,5005,525-50%-$392,944
2017-11-08
NBIXNeurocrine Biosciences IncGrigoriadis Dimitri E.CHIEF RESEARCH OFFICERS - Sale$74.58-30,00077,691-28%-$2,237,343
2017-11-10
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$13.26-5,49016,473-25%-$72,797
2017-11-09
ADMAAdma Biologics, Inc.Biotest AGDir, 10%P - Purchase$2.15+5,813,95410,109,534+135%+$12,500,001
2017-11-09
ADMAAdma Biologics, Inc.Richman Eric IDirP - Purchase$2.15+25,00031,300+397%+$53,750
2017-11-09
ADMAAdma Biologics, Inc.Lenz BrianVP, CFOP - Purchase$2.15+6,50015,000+76%+$13,975
2017-11-09
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOP - Purchase$2.15+485,000744,000+187%+$1,042,750
2017-11-09
ADMAAdma Biologics, Inc.Mond JamesEVP, CSO, CMOP - Purchase$2.15+10,00013,389+295%+$21,500
2017-11-09
NVAXNovavax IncGlenn Gregory MPres, R, DP - Purchase$1.13+10,00014,427+226%+$11,300
2017-11-09
NVAXNovavax IncErck Stanley CPres, CEOP - Purchase$1.13+100,000228,279+78%+$113,050
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Hbm Biocapital II LP10%P - Purchase$14.00+71,4283,205,232+2%+$999,992
2017-11-08
AMGNAmgen IncDe Carbonnel FrancoisDirS - Sale$173.60-4,00015,528-20%-$694,422
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Bessemer Venture Partners VII L.P.10%P - Purchase$14.00+36,0002,263,365+2%+$504,000
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Topper James NDir, 10%P - Purchase$14.00+500,0003,330,373+18%+$7,000,000
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Tepper Robert IDir, 10%P - Purchase$14.00+215,0002,790,964+8%+$3,010,000
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Kraus StephenDirP - Purchase$0.00+00-32768%+$0
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Fhm Vi, L.L.C.10%P - Purchase$14.00+500,0003,330,373+18%+$7,000,000
D
2017-11-02
NBIXNeurocrine Biosciences IncObrien Christopher FlintCHIEF MEDICAL OFFICERS - Sale+OE$69.71-52,81748,973-52%-$3,681,641
D
2017-11-02
NBIXNeurocrine Biosciences IncGano KyleChief Business Development OffS - Sale+OE$71.05-24,81873,246-25%-$1,763,319
D
2017-11-06
ALNAAllena Pharmaceuticals, Inc.Third Rock Ventures Ii, L.P.10%P - Purchase$14.00+215,0002,790,964+8%+$3,010,000
D
2017-10-31
ONCESpark Therapeutics, Inc.High Katherine ASee RemarksS - Sale+OE$83.30-5,000210,000-2%-$416,500
D
2017-11-02
JUNOJuno Therapeutics, Inc.Azelby RobertEVP, Chief Commercial OfficerS - Sale+OE$54.95-6,66673,332-8%-$366,297
D
2017-11-01
GILDGilead Sciences IncMartin John CExec COBS - Sale+OE$75.13-73,3332,996,766-2%-$5,509,697
D
2017-11-01
GILDGilead Sciences IncAlton Gregg HEVP Comm, Acs ALA, Corp, Med AS - Sale+OE$74.82-15,00062,363-19%-$1,122,285
2017-11-01
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$60.91-39,385178,992-18%-$2,398,915
D
2017-11-01
AVXSAvexis, Inc.Nagendran SukumarSVP, Chief Medical OfficerS - Sale+OE$101.26-1,7800-100%-$180,244
2017-11-01
AVXSAvexis, Inc.Kaspar Brian K.Chief Scientific Officer, 10%S - Sale$101.23-15,0001,826,802-1%-$1,518,416
2017-11-01
EDITEditas Medicine, Inc.Bosley KatrinePres, CEOS - Sale$23.64-8,3331,391,097-1%-$196,966
D
2017-11-01
TECHBio-Techne CorpBaumgartner Robert VDirS - Sale+OE$130.18-5,0007,712-39%-$650,907
D
2017-11-01
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief FinancialS - Sale+OE$151.38-35,00027,305-56%-$5,298,326
D
2017-11-01
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale+OE$145.17-2,127272,545-1%-$308,779
D
2017-11-01
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$144.31-2,25027,484-8%-$324,690
D
2017-11-01
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$145.21-4,00015,977-20%-$580,822
AM
2017-10-27
AGENAgenus IncArmen Garo HCOB, CEOP - Purchase$3.55+100,0001,594,487+7%+$355,115
2017-10-26
IDRAIdera Pharmaceuticals, Inc.Baker Bros. Advisors LPDirP - Purchase$1.50+8,000,00016,711,971+92%+$12,000,000
M
2017-10-26
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$13.59-4,4001,161,9450%-$59,774
D
2017-10-25
ASTAsterias Biotherapeutics, Inc.Mulroy Michael H.Pres, CEOP - Purchase$2.55+1,9393,476+126%+$4,944
2017-10-24
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.14-50,0004,880,399-1%-$56,750
2017-10-17
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.16-50,0004,930,399-1%-$58,135
2017-10-20
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale$32.62-10,00098,530-9%-$326,184
M
2017-10-20
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale$145.14-7,050272,545-3%-$1,023,268
DM
2017-10-20
ONCESpark Therapeutics, Inc.Faga DanielChief Business OfficerS - Sale+OE$80.96-7,5000-100%-$607,200
2017-10-17
BLUEBluebird Bio, Inc.Leschly NickPres, CEOS - Sale$145.05-10,823279,595-4%-$1,569,840
2017-10-16
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$33.25-5,00092,283-5%-$166,250
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Cola Michael FPres, CEOP - Purchase$1.26+119,047218,483+120%+$149,999
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Bauer Eugene ADirP - Purchase$1.26+19,841165,715+14%+$25,000
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Clemow Alastair JDirP - Purchase$1.26+19,84157,536+53%+$25,000
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Duncan Barbara GayleDirP - Purchase$1.26+59,52459,524New+$75,000
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Gantz Wilbur HDirP - Purchase$1.26+39,68371,073+126%+$50,001
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Neil Garry ArthurChief Scientific OfficerP - Purchase$1.26+75,000114,774+189%+$94,500
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Grano Joseph J JrDirP - Purchase$1.26+39,683113,847+54%+$50,001
D
2017-10-17
GNMXAevi Genomic Medicine, Inc.Barer Sol JDirP - Purchase$1.26+421,0321,547,732+37%+$530,500
2017-10-13
BTXBiotime IncBroadwood Partners, L.P.Dir, 10%P - Purchase$2.60+2,692,30760,006,030+5%+$6,999,998
2017-10-16
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$14.35-6,000363,305-2%-$86,100
M
2017-10-13
FATEFate Therapeutics IncWolchko J ScottPres, CEOS - Sale$3.88-17,168124,881-12%-$66,600
M
2017-10-13
FATEFate Therapeutics IncTahl CindyGC, SecretaryS - Sale$3.85-8,09145,418-15%-$31,124
M
2017-10-13
FATEFate Therapeutics IncShoemaker Daniel DChief Scientific OfficerS - Sale$3.87-13,22590,591-13%-$51,203
D
2017-10-11
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$61.18-18,832687,146-3%-$1,152,234
D
2017-10-11
RGNXRegenxbio Inc.Hayden Donald J JrDirS - Sale+OE$34.95-20,0000-100%-$699,000
M
2017-10-11
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$15.02-4,4001,166,3450%-$66,066
2017-10-10
VYGRVoyager Therapeutics, Inc.Ravina BernardChief Medical OfficerS - Sale$20.33-10,98021,963-33%-$223,223
D
2017-10-10
TECHBio-Techne CorpLucas Roger CDirS - Sale+OE$121.95-1001,870-5%-$12,196
2017-10-10
MBOTMicrobot Medical Inc.Bornstein YosephDir, 10%S - Sale$1.38-50,00010,040,8180%-$68,905
2017-10-09
AVXSAvexis, Inc.Kaspar Brian K.Chief Scientific Officer, 10%S - Sale$101.46-15,0001,841,802-1%-$1,521,843

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top